Simulation of clinical trials

被引:178
作者
Holford, NHG
Kimko, HC
Monteleone, JPR
Peck, CC
机构
[1] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand
[2] Georgetown Univ, Med Ctr, Dept Pharmacol, Ctr Drug Dev Sci, Washington, DC 20007 USA
关键词
design optimization; pharmacokinetics; pharmacodynamics;
D O I
10.1146/annurev.pharmtox.40.1.209
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Computer simulation of clinical trials has evolved over the past two decades from a simple instructive game to "full" simulation models yielding pharmacologically sound, realistic trial outcomes. The need to make drug development more efficient and informative and the awareness that many industries make extensive use of simulation in product development have advanced considerably the use of simulation of clinical trials in pharmaceutical product development over the past decade. The structural and stochastic components of trial simulation models are explained as a prelude to a Listing of representative simulation projects, reflecting investigative applications of statistical methods, trial design comparisons, and full simulation of new drugs being developed. Lessons learned from these projects are reviewed in the context of their current impact and potential for influencing the future of drug development.
引用
收藏
页码:209 / 234
页数:26
相关论文
共 71 条
[1]
Amstein R., 1996, PHARM RES, V13, pS452
[2]
BIES R, 1999, IN PRESS PHARM RES
[4]
BOECKMANN AJ, 1990, NONMEM USERS GUIDES
[5]
*CENT DRUG DEV SCI, 1997, MOD SIM CLIN TRIALS
[6]
*CENT DRUG DEV SCI, 1999, MOD SIM BEST PRACT W
[7]
*CENT DRUG DEV SCI, 1996, FRONT DRUG DEV COMP
[8]
SIMULTANEOUS PHARMACOKINETIC AND PHARMACODYNAMIC MODELING [J].
COLBURN, WA .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (03) :367-388
[9]
OPTIMAL SAMPLING TIMES FOR PHARMACOKINETIC EXPERIMENTS [J].
DARGENIO, DZ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (06) :739-756
[10]
DEMETS DL, 1981, CONTROL CLIN TRIALS, V1, P363